Legend Biotech Corp (LEGN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.10B
Last updated: Nov 17, 2026 at 4:39 PM ET
Legend Biotech Corp (LEGN) Stock Chart
Legend Biotech (LEGN) has a latest price of $16.11 on Nov 17, 2026, 57.0% below its 52-week high of $37.50. Its price fell 46.8% over the past 12 months. The month-end price fell 58.8% over the 5 years through Oct 2026, a compound annual decline of 16.3%.
Price Chart
From Jun 2020 to Oct 2026, its highest month-end close was $75.52 in Jul 2023 and its lowest $17.50 in Jan 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart LEGN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for LEGN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 28.7%, and over 6 months it fell 40.2%. The month-end price fell 67.3% over the 3 years through Oct 2026, a compound annual decline of 31.1%.
| Period | Change |
|---|---|
| 1 month | -13.6% |
| 3 months | -28.7% |
| 6 months | -40.2% |
| 12 months | -46.8% |
| 12 months, with dividends | -46.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -67.3% | -31.1% |
| 5 years | -58.8% | -16.3% |
Price by Year
Its best calendar year was 2021, when the price rose 65.5%, and its weakest was 2024, when it fell 45.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $21.63 | -0.5% |
| 2025 | $21.74 | -33.2% |
| 2024 | $32.54 | -45.9% |
| 2023 | $60.17 | +20.5% |
| 2022 | $49.92 | +7.1% |
| 2021 | $46.61 | +65.5% |
Trading Range
The price is 16.8% below its 50-day average of $19.37 and 27.4% below its 200-day average of $22.18.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $16.11 | |
| 52-week high | $37.50 | -57.0% |
| 52-week low | $15.97 | +0.9% |
| 50-day average | $19.37 | -16.8% |
| 200-day average | $22.18 | -27.4% |
Price Risk
Over 3 years, its largest fall from a peak was 77.2%.
| Measure | Value |
|---|---|
| 1-year beta | 0.67 |
| Largest fall, 1 year | -55.9% |
| Largest fall, 3 years | -77.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About LEGN
What is LEGN's 1-year price change?
Legend Biotech's price fell 46.8% over the past 12 months. With dividends included, the 12-month total return was -46.8%.
What is LEGN's 5-year price change?
Legend Biotech's month-end price fell 58.8% over the 5 years through Oct 2026, a compound annual decline of 16.3%. These figures leave out dividends.
What is LEGN's 52-week high and low?
Legend Biotech's 52-week high is $37.50 and its 52-week low is $15.97. Its latest price of $16.11 on Nov 17, 2026 is 57.0% below the high.
What is LEGN's beta?
Legend Biotech's 1-year beta against the S&P 500 is 0.67, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 55.9%.
Is the LEGN chart free?
Yes. Advanced Charting for LEGN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
LEGN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors